Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

Simple Summary Prostate cancer treatment with radiation therapy has advanced
significantly over the years. Leveraging the proposed low α/β ratio of prostate cancer …

Background Previous evidence supports androgen deprivation therapy (ADT) with primary
radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer …

Background Previous evidence indicates that adjuvant, short-course androgen deprivation
therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for …

Background and purpose There is no consensus concerning the appropriate use of
androgen deprivation therapy (ADT) during primary and postoperative external-beam …

中国初诊的前列腺癌患者中40%~ 70% 已处于转移性疾病阶段, 而前列腺癌发生,
发展的时空异质性及独特的转移模式使得基于活检组织取材分析免疫标志物的方式困难重重 …

Purpose Despite growing evidence for bilateral pelvic radiotherapy (whole pelvis RT,
WPRT) there is almost no data on unilateral RT (hemi pelvis RT, HPRT) in patients with …

Background Ultra-hypofractionated image-guided stereotactic body radiotherapy (SBRT) is
increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance …

PURPOSE We sought to investigate whether enzalutamide (ENZA), without concurrent
androgen deprivation therapy, increases freedom from prostate-specific antigen (PSA) …